Atrial natriuretic peptide reduces expression of TNF-α mRNA during reperfusion of the rat liver upon decreased activation of NF-κB and AP-1

Journal of Hepatology

Volumn 33, Issue 2, 2000, Pages 236-246

  Kiemer, Alexandra K ^a,b   Vollmar, Angelika M ^b   Bilzer, Manfred ^a   Gerwig, Tobias ^a,b   Gerbes, Alexander L ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Center of Drug Research   (Germany)

Author keywords

cGMP; Cytokine; Hepatoprotection; Hormonal preconditioning; Transcription factors

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLOOXYGENASE 2; GUANOSINE PHOSPHATE; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; DNA BINDING; IMMUNOBLOTTING; IMMUNOMODULATION; LIVER ISCHEMIA; MACROPHAGE; MALE; NONHUMAN; NORTHERN BLOTTING; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

EID: 0033930320     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80364-5     Document Type: Article

References (51)

1. Jaeschke H. Preservation injury: mechanisms, prevention and consequences. J Hepatol. 25:1996;774-780.
2. Jaeschke H. Reactive oxygen and ischemìa/reperfusion injury of the liver. Chem Biol Interact. 79:1991;115-136.
3. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock. 6:1996;79-88.
4. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 85:1990;1936-1943.
5. Hoffmann MW, Wonigeit K, Steinhoff G, Herzbeck H, Flad HD, Pichlmayr R. Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation. 55:1993;329-335.
6. Goto M, Takei Y, Kawano S, Tsuji S, Fukui H, Fushimi H, et al. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat. Hepatology. 16:1992;487-493.
7. Müller JM, Rupec RA, Baeuerle PA. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods. 11:1997;301-312.
8. Marra F. Ischemia-reperfusion: the liver under stress. Hepatology. 25:1997;1276-1278.
9. Grisham MB. NF-kappa B activation in acute pancreatitis: protective, detrimental, or inconsequential? Gastroenterology. 116:1999;489-492.
10. Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM. NF-kappa B/Rel activation in cerulein pancreatitis. Gastroenterology. 116:1999;420-430.
11. Rosenzweig A, Seidman CEE. Atrial natriuretic factor and related peptide hormones. Ann Rev Biochem. 60:1991;229-255.
12. Samson W, Levin ER. Natriuretic Peptides in Health and Disease. 1997;Humana Press, Tutowa, NJ.
13. Kiemer AK, Vollmar AM. Autocrine regulation of the inducible nitric oxide synthase by Atrial Natriuretic Peptide in macrophages. J Biol Chem. 273:1998;13444-13451.
14. Vollmar AM, Schulz R. Expression and differential regulation of natriuretic peptides in mouse macrophages. J Clin Invest. 95:1995;2442-2450.
15. Kiemer AK, Vollmar AM. Effects of different natriuretic peptides on nitric oxide synthesis in macrophages. Endocrinology. 138:1997;4282-4290.
16. Vollmar AM, Schulz R. Gene expression and secretion of Atrial Natriuretic Peptide by murine macrophages. J Clin Invest. 94:1994;539-545.
17. Bilzer M, Witthaut R, Paumgartner G, Gerbes AL. Prevention of ischemia/reperfusion injury in the rat liver by atrial natriuretic peptide. Gastroenterology. 106:1994;143-151.
18. Gerbes AL, Vollmar AM, Kiemer AK, Bilzer M. The guanylatecyclase coupled natriuretic peptide (GC-A) receptor - a new target for prevention of cold ischemia-reperfusion damage. Hepatology. 28:1998;1309-1317.
19. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 12:1994;141-179.
20. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
21. Sung SJ, Walters JA, Hudson J, Gimble JM. Tumor necrosis factor-alpha mRNA accumulation in human myelomonocytic cell lines. Role of transcriptional regulation by DNA sequence motifs and mRNA stabilization. J Immunol. 147:1991;2047-2054.
22. Spriggs DR, Deutsch S, Kufe DW. Genomic structure, induction, and production of TNF-alpha. Immunol Ser. 6:1995;3-34.
23. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 269:1994;4705-4708.
24. Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med. 177:1993;1779-1784.
25. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 9:1997;240-246.
26. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J. 11:1997;118-124.
27. Förstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedebergs-Arch Pharmacol. 352:1995;351-364.
28. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta. 1299:1996;125-140.
29. Sies H. The use of perfusion of liver and other organs for the study of microsomal electron-transport and cytochrome P-450 systems. Methods Enzymol. 52:1978;48-59.
30. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with"mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-271.
32. Luss H, Watkins SC, Freeswick PD, Imro AK, Nussler AK, Billiar TR, et al. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol. 27:1995;2015-2029.
33. Chen F, Sun SC, Kuhn DC, Gaydos J, Shi XL, Lu YJ, et al. Involvement of NF-kappa B in silica-induced cyclooxygenase II gene expression in rat alveolar macrophages. Am J Physiol. 16:1997;L779-L786.
34. Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G, et al. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology. 25:1997;1128-1135.
35. Vollmar AM, Schmidt KN, Schulz R. Natriuretic peptide receptors on rat thymocytes: inhibition of proliferation by atrial natriuretic peptide. Endocrinology. 137:1996;1706-1713.
36. Tacchini L, Radice L, Pogliaghi G, Bernelli-Zazzera A. Differential activation of heat shock proteins and nuclear factor κB transcription factors in postischemic reperfused rat liver. Hepatology. 26:1997;186-191.
37. Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology. 28:1998;1022-1030.
38. Tran-Thi TA, Decker K, Baeuerle PA. Differential activation of transcription factors NF-kappa B and AP-1 in rat liver macrophages. Hepatology. 22:1995;613-619.
39. Rupec RA, Baeuerle PA. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NFκB. Eur J Biochem. 234:1995;632-640.
40. Chandrasekar B, Freeman GL. Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Lett. 401:1997;30-34.
41. Diehl AM, Yin M, Fleckenstein J, Yang SQ, Lin HZ, Brenner DA, et al. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am J Physiol. 264:1994;G552-G561.
42. Biesiada E, Razandi M, Levin ER. Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation. J Biol Chem. 271:1996;18576-18581.
43. Bradham CA, Schemmer P, Stachlewitz RF, Thurman RG, Brenner DA. Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transpl Surg. 5:1999;282-293.
44. Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology. 30:1999;203-208.
45. Essani NA, McGuire GM, Manning AM, Jaeschke H. Differential induction of mRNA for ICAM-1 and selectins in hepatocytes, Kupffer cells and endothelial cells during endotoxemia. Biochem Biophys Res Commun. 211:1995;74-82.
46. Xu Y, Bradham C, Brenner DA, Czaja MJ. Hydrogen peroxideinduced liver cell necrosis is dependent on AP-1 activation. Am J Physiol. 36:1997;G797-G803.
47. Ma TT, Ischiropoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology. 108:1995;463-469.
48. Clemens MG, Bauer M, Pannen BHJ, Bauer I, Zhang JX. Remodeling of hepatic microvascular responsiveness after ischemia/reperfusion. Shock. 8:1997;80-85.
49. Le Moine O, Louis H, Stordeur P, Collet JM, Goldman M, Deviere J. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology. 113:1997;1701-1706.
50. Sankary HN, Foster P, Brown E, Williams J. Do splanchnic viscera contribute to liver preservation reperfusion injury? Transplantation. 61:1996;1142-1147.
51. Bilzer M, Gerbes AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol. 32:2000;508-515.